High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA
Acute promyelocytic leukemia (APL) is classically characterized by chromosomal translocation (15;17), resulting in the PML-RARA fusion protein leading to disease. Here, we present a case of a 50-year-old man who presented with signs and symptoms of acute leukemia with concern for APL. Therapy was im...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2015/343854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832548772050108416 |
|---|---|
| author | Benjamin Powers Diane Persons Deepthi Rao Janet Woodroof Tara L. Lin |
| author_facet | Benjamin Powers Diane Persons Deepthi Rao Janet Woodroof Tara L. Lin |
| author_sort | Benjamin Powers |
| collection | DOAJ |
| description | Acute promyelocytic leukemia (APL) is classically characterized by chromosomal translocation (15;17), resulting in the PML-RARA fusion protein leading to disease. Here, we present a case of a 50-year-old man who presented with signs and symptoms of acute leukemia with concern for APL. Therapy was immediately initiated with all-trans retinoic acid. The morphology of his leukemic blasts was consistent with the hypogranular variant of APL. Subsequent FISH and cytogenetic analysis revealed a unique translocation involving five chromosomal regions: 9q34, 17q21, 15q24, 12q13, and 15q26.1. Molecular testing demonstrated PML/RARA fusion transcripts. Treatment with conventional chemotherapy was added and he went into a complete remission. Given his elevated white blood cell count at presentation, intrathecal chemotherapy for central nervous system prophylaxis was also given. The patient remains on maintenance therapy and remains in remission. This is the first such report of a 5-way chromosomal translocation leading to APL. Similar to APL with chromosomal translocations other than classical t(15;17) which result in the typical PML-RARA fusion, our patient responded promptly to an ATRA-containing regimen and remains in complete remission. |
| format | Article |
| id | doaj-art-8a9723db4e134a70b088fd13fe01e21b |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-8a9723db4e134a70b088fd13fe01e21b2025-02-03T06:13:11ZengWileyCase Reports in Hematology2090-65602090-65792015-01-01201510.1155/2015/343854343854High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARABenjamin Powers0Diane Persons1Deepthi Rao2Janet Woodroof3Tara L. Lin4Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66210, USADepartment of Pathology and Laboratory Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66210, USADepartment of Pathology and Laboratory Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66210, USADepartment of Pathology and Laboratory Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66210, USADivision of Hematology/Oncology, Department of Internal Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66210, USAAcute promyelocytic leukemia (APL) is classically characterized by chromosomal translocation (15;17), resulting in the PML-RARA fusion protein leading to disease. Here, we present a case of a 50-year-old man who presented with signs and symptoms of acute leukemia with concern for APL. Therapy was immediately initiated with all-trans retinoic acid. The morphology of his leukemic blasts was consistent with the hypogranular variant of APL. Subsequent FISH and cytogenetic analysis revealed a unique translocation involving five chromosomal regions: 9q34, 17q21, 15q24, 12q13, and 15q26.1. Molecular testing demonstrated PML/RARA fusion transcripts. Treatment with conventional chemotherapy was added and he went into a complete remission. Given his elevated white blood cell count at presentation, intrathecal chemotherapy for central nervous system prophylaxis was also given. The patient remains on maintenance therapy and remains in remission. This is the first such report of a 5-way chromosomal translocation leading to APL. Similar to APL with chromosomal translocations other than classical t(15;17) which result in the typical PML-RARA fusion, our patient responded promptly to an ATRA-containing regimen and remains in complete remission.http://dx.doi.org/10.1155/2015/343854 |
| spellingShingle | Benjamin Powers Diane Persons Deepthi Rao Janet Woodroof Tara L. Lin High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA Case Reports in Hematology |
| title | High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA |
| title_full | High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA |
| title_fullStr | High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA |
| title_full_unstemmed | High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA |
| title_short | High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA |
| title_sort | high risk microgranular acute promyelocytic leukemia with a five way complex translocation involving pml rara |
| url | http://dx.doi.org/10.1155/2015/343854 |
| work_keys_str_mv | AT benjaminpowers highriskmicrogranularacutepromyelocyticleukemiawithafivewaycomplextranslocationinvolvingpmlrara AT dianepersons highriskmicrogranularacutepromyelocyticleukemiawithafivewaycomplextranslocationinvolvingpmlrara AT deepthirao highriskmicrogranularacutepromyelocyticleukemiawithafivewaycomplextranslocationinvolvingpmlrara AT janetwoodroof highriskmicrogranularacutepromyelocyticleukemiawithafivewaycomplextranslocationinvolvingpmlrara AT tarallin highriskmicrogranularacutepromyelocyticleukemiawithafivewaycomplextranslocationinvolvingpmlrara |